Last edition
News about Global Pharma
Sandoz to Bolster Ophthalmology Portfolio Through Acquisition of CIMERLI Biosimilar
The acquisition aligns with Sandoz's dedication to providing expanded treatment options for US patients dealing with vision impairment and loss.
Global Pharma | 22/01/2024 | By Manvi | 756
Progeria Research Foundation's Zokinvy Receives Approval in Japan for Progeria Treatment
PRF, a pioneering force in rare disease research, has been at the forefront of Zokinvy clinical trial research since 2007.
Global Pharma | 22/01/2024 | By Manvi | 590
Johnson & Johnson's BALVERSA Granted Full FDA Approval for Advanced Urothelial Carcinoma Treatment
This approval is specifically for patients whose disease has progressed after at least one prior systemic therapy, excluding those eligible for and not having received prior PD-1 or PD-L1 inhibitor therapy.
Global Pharma | 20/01/2024 | By Manvi | 956
India's Cancer Diagnostics Market Thrives with Technological Advancements and Government Initiatives
The latest market research report, 'India Cancer Diagnostics Market, By Region, Competition Forecast and Opportunities, 2019-2029F,' offers a comprehensive analysis covering key aspects such as product innovation, market drivers, challenges, trends, and regional insights.
Global Pharma | 20/01/2024 | By Manvi | 738
MECO Appoints Gregory Queen as New President
Greg will be a member of the Grundfos Water Treatment Solutions Leadership Team.
Global Pharma | 20/01/2024 | By Manvi | 861
Sun Pharma to Acquire Taro Pharmaceutical Industries in Definitive Merger Agreement
The agreement outlines Sun Pharma's acquisition of all outstanding ordinary shares of Taro, excluding those already held by Sun Pharma or its affiliates.
Global Pharma | 19/01/2024 | By Manvi | 269
Hoth Therapeutics Receives FDA Clearance for Protocol Amendments in HT-001 Clinical Trial
The drug is being developed as a potential treatment for cancer patients experiencing skin toxicities associated with Epidermal Growth Factor Receptor Inhibitors (EGFRI).
Global Pharma | 19/01/2024 | By Manvi | 496
LogiPharma Launches 2024 Agenda Featuring Big Pharma Players
LogiPharma has unveiled its highly anticipated 2024 agenda, spotlighting key themes and speakers for this year's show, which takes place in Lyon, France, 16th – 18th April.
Global Pharma | 19/01/2024 | By Manvi | 549
Union Cabinet Approves MoI Between India's CDSCO and Netherlands
The MoI, signed on 7th November 2023, sets the stage for collaborative efforts in the field of Medical Products Regulation.
Global Pharma | 19/01/2024 | By Manvi | 380
The agreement aims to promote the exchange of information and collaboration in areas related to medical products, as well as administrative and regulatory matters within the jurisdictions of both parties.
Global Pharma | 19/01/2024 | By Manvi | 584
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy